Early Results of Pilot Study Using Hepatitis C Virus (HCV) Positive Kidneys to Transplant HCV Infected Patients with End-Stage Renal Disease Allowing for Successful Interferon-Free Direct Acting Antiviral Therapy after Transplantation

Introduction: Hepatitis C virus (HCV) infection in kidney transplant (KTX) patients reduces long-term patient and graft survival. Direct-acting antivirals (DAA) are > 90% effective in achieving sustained viral response (SVR); however, DAAs are not routinely available to patients with end-stage re...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallegos-Orozco, Juan F, Kim, Robin, Thiesset, Heather F, Hatch, Jenny, Lynch, Keisa, Chaly, Jr, Thomas, Shihab, Fuad, Ahmed, Faris, Hall, Isaac, Campsen, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2016
Materias:
Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179247/
https://www.ncbi.nlm.nih.gov/pubmed/28018760
http://dx.doi.org/10.7759/cureus.890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179247/
https://www.ncbi.nlm.nih.gov/pubmed/28018760
http://dx.doi.org/10.7759/cureus.890

Ejemplares similares